P2 receptors and neuronal injury

Pflugers Archiv European Journal of Physiology

Volumn 452, Issue 5, 2006, Pages 622-644

  Franke, Heike ^a   Krügel, Ute ^a   Illes, Peter ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Astroglia; Extracellular ATP; Neurodegeneration; Neuronal injury; Neuronal plasticity; Neuroprotection; P2 receptors

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; ADENOSINE TRIPHOSPHATE; CATION CHANNEL; G PROTEIN COUPLED RECEPTOR; GAP JUNCTION PROTEIN; GLUTAMIC ACID; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR; NEUROTRANSMITTER; PROTEIN TYROSINE KINASE A; PURINE P2 RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2X2 RECEPTOR; PURINE P2X3 RECEPTOR; PURINE P2X4 RECEPTOR; PURINE P2X5 RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y11 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y6 RECEPTOR; UNINDEXED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2; VESICULAR GLUTAMATE TRANSPORTER 3;

BRAIN INJURY; CELL COMMUNICATION; EXOCYTOSIS; EXTRACELLULAR SPACE; GLIA; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL LESION; NERVE DEGENERATION; NERVE REGENERATION; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; ASTROCYTES; BRAIN; BRAIN DISEASES; HUMANS; NERVE REGENERATION; NEURONAL PLASTICITY; NEURONS; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 33745737217     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-006-0071-8     Document Type: Review

References (349)

1. Fields RD, Stevens-Graham B (2002) New insights into neuron-glia communication. Science 298:556-562
2. Burnstock G (2004) Cotransmission. Curr Opin Pharmacol 4:47-52
3. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
4. Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MA, Reed JK, Ciccarelli R, Di Iorio P, Caciagli F (1999) Trophic effects of purines in neurons and glial cells. Prog Neurobiol 59:663-690
5. Volonte C, Amadio S, Cavaliere F, D'Ambrosi N, Vacca F, Bernardi G (2003) Extracellular ATP and neurodegeneration. Curr Drug Targets CNS Neurol Disord 2:403-412
6. Franke H, Illes P (2006) Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther 109:297-324
7. Dubyak GR, el-Moatassim C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265:C577-C606
8. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Collo G, Buell G, Di Virgilio F (1997) ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36:1295-1301
9. Bodin P, Burnstock G (1998) Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res 47:351-354
10. Neary JT, McCarthy M, Cornell-Bell A, Kang Y (1999) Trophic signaling pathways activated by purinergic receptors in rat and human astroglia. Prog Brain Res 120:323-332
11. 2+ signalling in glial cell pathology in the central nervous system. Eur J Pharmacol 447:247-260
12. Amadio S, D'Ambrosi N, Cavaliere F, Murra B, Sancesario G, Bernardi G, Burnstock G, Volonte C (2002) P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 42:489-501
13. D'Ambrosi N, Murra B, Cavaliere F, Amadio S, Bernardi G, Burnstock G, Volonte C (2001) Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells. Neuroscience 108:527-534
14. Neary JT, Zhu Q (1994) Signaling by ATP receptors in astrocytes. Neuroreport 5:1617-1620
15. Abbracchio MP, Ceruti S, Barbieri D, Franceschi C, Malorni W, Biondo L, Burnstock G, Cattabeni F (1995) A novel action for adenosine: apoptosis of astroglial cells in rat brain primary cultures. Biochem Biophys Res Commun 213:908-915
16. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318
17. Minghetti L, Polazzi E, Nicolini A, Greco A, Levi G (1999) Possible role of microglial prostanoids and free radicals in neuroprotection and neurodegeneration. Adv Exp Med Biol 468:109-119
18. 7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells. J Neurochem 87:344-352
19. 7 receptor-activated microglia. J Neurosci 24:1-7
20. Marchetti B, Abbracchio MP (2005) To be or not to be (inflamed) - is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? Trends Pharmacol Sci 26:517-525
21. Silinsky EM (1975) On the association between transmitter secretion and the release of adenine nucleotides from mammalian motor nerve terminals. J Physiol 247:145-162
22. Burnstock G (1986) Purines and cotransmitters in adrenergic and cholinergic neurones. Prog Brain Res 68:193-203
23. Richardson PJ, Brown SJ (1987) ATP release from affinity-purified rat cholinergic nerve terminals. J Neurochem 48:622-630
24. von Kügelgen I (1994) Purinoceptors modulating the release of noradrenaline. J Auton Pharmacol 14:11-12
25. Jo YH, Schlichter R (1999) Synaptic corelease of ATP and GABA in cultured spinal neurons. Nat Neurosci 2:241-245
26. Jo YH, Role LW (2002) Coordinate release of ATP and GABA at in vitro synapses of lateral hypothalamic neurons. J Neurosci 22:4794-4804
27. Rubio ME, Soto F (2001) Distinct localization of P2X receptors at excitatory postsynaptic specializations. J Neurosci 21:641-653
28. Cunha RA, Vizi ES, Ribeiro JA, Sebastiao AM (1996) Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high - but not low - frequency stimulation of rat hippocampal slices. J Neurochem 67:2180-2187
29. Vizi ES, Liang SD, Sperlagh B, Kittel A, Juranyi Z (1997) Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: support for neurotransmitter role of ATP. Neuroscience 79:893-903
30. 7 receptors. Neurochem Int 33:209-215
31. Craig CG, White TD (1992) Low-level N-methyl-D-aspartate receptor activation provides a purinergic inhibitory threshold against further N-methyl-D-aspartate-mediated neurotransmission in the cortex. J Pharmacol Exp Ther 260:1278-1284
32. Craig CG, White TD (1993) N-methyl-D-aspartate- and non-N-methyl-D- aspartate-evoked adenosine release from rat cortical slices: distinct purinergic sources and mechanisms of release. J Neurochem 60:1073-1080
33. Gereau RW, Conn PJ (1994) Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism. Neuron 12:1121-1129
34. Rosenberg PA, Li Y (1995) Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by beta-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex. Brain Res 692:227-232
35. Pellegatti P, Falzoni S, Pinton P, Rizzuto R, Di Virgilio F (2005) A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol Biol Cell 16:3659-3665
36. Queiroz G, Meyer DK, Meyer A, Starke K, von Kügelgen I (1999) A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience 91:1171-1181
37. Cotrina ML, Lin JH, Lopez-Garcia JC, Naus CC, Nedergaard M (2000) ATP-mediated glia signaling. J Neurosci 20:2835-2844
38. Arcuino G, Lin JH, Takano T, Liu C, Jiang L, Gao Q, Kang J, Nedergaard M (2002) Intercellular calcium signaling mediated by point-source burst release of ATP. Proc Natl Acad Sci USA 99:9840-9845
39. Coco S, Calegari F, Pravettoni E, Pozzi D, Taverna E, Rosa P, Matteoli M, Verderio C (2003) Storage and release of ATP from astrocytes in culture. J Biol Chem 278:1354-1362
40. 7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci 23:1320-1328
41. Newman EA (2003) New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci 26:536-542
42. 1 receptors in connexin43-null mice alters calcium signaling and migration of neural progenitor cells. J Neurosci 23:11444-11452
43. Burnstock G (1997) The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36:1127-1139
44. Rothman JE (1994) Mechanisms of intracellular protein transport. Nature 372:55-63
45. 2+-triggered exocytosis. Science 298:781-785
46. Lazarowski ER, Boucher RC, Harden TK (2003) Mechanisms of release of nucleotides and integration of their action as P2X-and P2Y-receptor activating molecules. Mol Pharmacol 64:785-795
47. Prat AG, Reisin IL, Ausiello DA, Cantiello HF (1996) Cellular ATP release by the cystic fibrosis transmembrane conductance regulator. Am J Physiol 270:C538-C545
48. Naumann N, Siratska O, Gahr M, Rosen-Wolff A (2005) P-glycoprotein expression increases ATP release in respiratory cystic fibrosis cells. J Cyst Fibros 4:157-168
49. Cotrina ML, Lin JH, Alves-Rodrigues A, Liu S, Li J, Azmi-Ghadimi H, Kang J, Naus CC, Nedergaard M (1998) Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA 95:15735-15740
50. De Vuyst E, Decrock E, Cabooter L, Dubyak GR, Naus CC, Evans WH, Leybaert L (2006) Intracellular calcium changes trigger connexin 32 hemichannel opening. EMBO J 25:34-44
51. Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341(Pt 2):233-249
52. Okada SF, O'Neal WK, Huang P, Nicholas RA, Ostrowski LE, Craigen WJ, Lazarowski ER, Boucher RC (2004) Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in murine cells. J Gen Physiol 124:513-526
53. Boudreault F, Grygorczyk R (2002) Cell swelling-induced ATP release and gadolinium-sensitive channels. Am J Physiol Cell Physiol 282:C219-C226
54. Lazarowski ER, Boucher RC, Harden TK (2000) Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem 275:31061-31068
55. Casel D, Brockhaus J, Deitmer JW (2005) Enhancement of spontaneous synaptic activity in rat Purkinje neurones by ATP during development. J Physiol 568:111-122
56. Bodin P, Burnstock G (2001) Purinergic signalling: ATP release. Neurochem Res 26:959-969
57. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271:33116-33122
58. 2+)-apyrase. J Biol Chem 271:9898-9901
59. Zimmermann H, Braun N (1999) Ecto-nucleotidases - molecular structures, catalytic properties, and functional roles in the nervous system. Prog Brain Res 120:371-385
60. Beaudoin AR, Grondin G, Gendron FP (1999) Immunolocalization of ATP diphosphohydrolase in pig and mouse brains, and sensory organs of the mouse. Prog Brain Res 120:387-395
61. Dunwiddie TV, Diao L, Proctor WR (1997) Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J Neurosci 17:7673-7682
62. Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362:299-309
63. Shukla V, Zimmermann H, Wang L, Kettenmann H, Raab S, Hammer K, Sevigny J, Robson SC, Braun N (2005) Functional expression of the ecto-ATPase NTPDase2 and of nucleotide receptors by neuronal progenitor cells in the adult murine hippocampus. J Neurosci Res 80:600-610
64. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH (1999) Adenosine triphosphate: established and potential clinical applications. Drugs 58:211-232
65. 2+ waves are propagated via ATP release and purinergic receptor activation". Am J Physiol Cell Physiol 279:C281-C283
66. Franke H, Grummich B, Härtig W, Grosche J, Regenthal R, Edwards RH, Illes P, Krügel U (2006) Changes in purinergic signaling after cerebral injury - involvement of glutamatergic mechanisms? Int J Dev Neurosci 24:123-132
67. Hagberg H, Andersson P, Lacarewicz J, Jacobson I, Butcher S, Sandberg M (1987) Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem 49:227-231
68. Gordon JL (1986) Extracellular ATP: effects, sources and fate. Biochem J 233:309-319
69. Deuticke B, Gerlach E, Dierkesmann R (1966) Decomposition of free nucleotides in the rat heart, skeletal muscle, brain and liver in oxygen deficiency. Pflügers Arch Gesamte Physiol Menschen Tiere 292:239-254
70. Ferguson DR, Kennedy I, Burton TJ (1997) ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes - a possible sensory mechanism? J Physiol 505(Pt 2):503-511
71. Okada Y, Maeno E, Shimizu T, Dezaki K, Wang J, Morishima S (2001) Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol 532:3-16
72. Wang EC, Lee JM, Ruiz WG, Balestreire EM, von Bodungen M, Barrick S, Cockayne DA, Birder LA, Apodaca G (2005) ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 115:2412-2422
73. Hamada K, Takuwa N, Yokoyama K, Takuwa Y (1998) Stretch activates Jun N-terminal kinase/stress-activated protein kinase in vascular smooth muscle cells through mechanisms involving autocrine ATP stimulation of purinoceptors. J Biol Chem 273:6334-6340
74. Yang S, Cheek DJ, Westfall DP, Buxton IL (1994) Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 74:401-407
75. Ostrom RS, Gregorian C, Insel PA (2000) Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J Biol Chem 275:11735-11739
76. Gourine AV, Llaudet E, Dale N, Spyer KM (2005) ATP is a mediator of chemosensory transduction in the central nervous system. Nature 436:108-111
77. Braun N, Zhu Y, Krieglstein J, Culmsee C, Zimmermann H (1998) Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci 18:4891-4900
78. Melani A, Turchi D, Vannucchi MG, Cipriani S, Gianfriddo M, Pedata F (2005) ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int 47:442-448
79. 7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10:821-827
80. Wieraszko A, Seyfried TN (1989) Increased amount of extracellular ATP in stimulated hippocampal slices of seizure prone mice. Neurosci Lett 106:287-293
81. Edwards FA (1996) Features of P2X receptor-mediated synapses in the rat brain: why doesn't ATP kill the postsynaptic cell? Ciba Found Symp 198:278-286
82. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH (1997) Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 185:153-163
83. Zimmermann H (1996) Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog Neurobiol 49:589-618
84. 14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24:52-55
85. von Kügelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther (in press)
86. 4 receptors in the rat hippocampus. J Neurosci 25:6286-6295
87. Rundén-Pran E, Tanso R, Haug FM, Ottersen OP, Ring A (2005) Neuroprotective effects of inhibiting N-methyl-d-aspartate receptors, P2X receptors and the mitogen-activated protein kinase cascade: a quantitative analysis in organotypical hippocampal slice cultures subjected to oxygen and glucose deprivation. Neuroscience 136:795-810
88. Illes P, Ribeiro JA (2004) Neuronal P2 receptors of the central nervous system. Curr Top Med Chem 4:831-838
89. Nörenberg W, Illes P (2000) Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch Pharmacol 362:324-339
90. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53:107-118
91. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067
92. Burnstock G (2006) Purinergic signalling. Br J Pharmacol 147:S172-S181
93. 11 receptor. Br J Pharmacol 128:1199-1206
94. i. J Biol Chem 276:41479-41485
95. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-207
96. Nakata H, Yoshioka K, Kamiya T, Tsuga H, Oyanagi K (2005) Functions of heteromeric association between adenosine and P2Y receptors. J Mol Neurosci 26:233-238
97. von Kügelgen I, Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 362:310-323
98. Abbracchio MP, Brambilla R, Ceruti S, Cattabeni F (1999) Signalling mechanisms involved in P2Y receptor-mediated reactive astrogliosis. Prog Brain Res 120:333-342
99. Neary JT, Kang Y, Bu Y, Yu E, Akong K, Peters CM (1999) Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J Neurosci 19:4211-4220
100. Brambilla R, Abbracchio MP (2001) Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann N Y Acad Sci 939:54-62
101. 2+- and nitric oxide-dependent stimulation of cyclic GMP synthesis in neuronal cell line induced by P2-purinergic/ pyrimidinergic receptor. J Neurochem 64:61-68
102. 1 receptor-mediated nitric oxide production. Neuropsychopharmacology 28:435-444
103. Viscomi MT, Florenzano F, Conversi D, Bernardi G, Molinari M (2004) Axotomy dependent purinergic and nitrergic co-expression. Neuroscience 123:393-404
104. Neary JT, Whittemore SR, Zhu Q, Norenberg MD (1994) Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP. J Neurochem 63:490-494
105. Neary JT, Zhu Q, Kang Y, Dash PK (1996) Extracellular ATP induces formation of AP-1 complexes in astrocytes via P2 purinoceptors. Neuroreport 7:2893-2896
106. 2 purinoreceptors in PC12 cells. Difference in purinoreceptor sensitivity in two PC12 cell lines. J Biol Chem 273:19965-19971
107. D'Ambrosi N, Cavaliere F, Merlo D, Milazzo L, Mercanti D, Volonte C (2000) Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells. Neuropharmacology 39:1083-1094
108. D'Ambrosi N, Murra B, Vacca F, Volonte C (2004) Pathways of survival induced by NGF and extracellular ATP after growth factor deprivation. Prog Brain Res 146:93-100
109. 2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C. J Biol Chem 273:2653-2660
110. Neary JT, Kang Y, Shi YF (2004) Signaling from nucleotide receptors to protein kinase cascades in astrocytes. Neurochem Res 29:2037-2042
111. Neary JT, Kang Y (2005) Signaling from P2 nucleotide receptors to protein kinase cascades induced by CNS injury: implications for reactive gliosis and neurodegeneration. Mol Neurobiol 31:95-103
112. Wang M, Kong Q, Gonzalez FA, Sun G, Erb L, Seye C, Weisman GA (2005) P2Y nucleotide receptor interaction with alpha integrin mediates astrocyte migration. J Neurochem 95:630-640
113. Gonzalez FA, Weisman GA, Erb L, Seye CI, Sun GY, Velazquez B, Hernandez-Perez M, Chorna NE (2005) Mechanisms for inhibition of P2 receptors signaling in neural cells. Mol Neurobiol 31:65-79
114. 2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes. Mol Neurobiol 31:169-183
115. Ryu JK, Choi HB, Hatori K, Heisel RL, Pelech SL, McLarnon JG, Kim SU (2003) Adenosine triphosphate induces proliferation of human neural stem cells: role of calcium and p70 ribosomal protein S6 kinase. J Neurosci Res 72:352-362
116. Cunha RA, Ribeiro JA (2000) ATP as a presynaptic modulator. Life Sci 68:119-137
117. Pankratov YV, Lalo UV, Krishtal OA (2002) Role for P2X receptors in long-term potentiation. J Neurosci 22:8363-8369
118. 7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 21:7143-7152
119. 3 subunits. Neurosci Lett 301:159-162
120. 3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations. Br J Pharmacol 121:913-922
121. 35S] dATP alpha S binding sites in the adult rat neuraxis. Neuropharmacology 36:1243-1251
122. Gu JG, MacDermott AB (1997) Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 389:749-753
123. Zimmermann H (1994) Signalling via ATP in the nervous system. Trends Neurosci 17:420-426
124. Wieraszko A, Goldsmith G, Seyfried TN (1989) Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Res 485:244-250
125. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634
126. Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG (1994) Glutamate-mediated astrocyte-neuron signalling. Nature 369:744-747
127. Jeremic A, Jeftinija K, Stevanovic J, Glavaski A, Jeftinija S (2001) ATP stimulates calcium-dependent glutamate release from cultured astrocytes. J Neurochem 77:664-675
128. Araque A, Carmignoto G, Haydon PG (2001) Dynamic signaling between astrocytes and neurons. Annu Rev Physiol 63:795-813
129. Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhauser C, Pilati E, Volterra A (2004) Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci 7:613-620
130. Fellin T, Pozzan T, Carmignoto G (2006) Purinergic receptors mediate two distinct glutamate release pathways in hippocampal astrocytes. J Biol Chem 281:4274-4284
131. Khakh BS, Gittermann D, Cockayne DA, Jones A (2003) ATP modulation of excitatory synapses onto interneurons. J Neurosci 23:7426-7437
132. 1 receptors in the hippocampal slice. J Neurosci 24:10835-10845
133. 7 receptor agonist 2′-3′-O-(4-benzoylbenzyl)-ATP. J Neurosci 24:7128-7139
134. Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM (2005) Adenosine and brain function. Int Rev Neurobiol 63:191-270
135. Mendoza-Fernandez V, Andrew RD, Barajas-Lopez C (2000) ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices. J Pharmacol Exp Ther 293:172-179
136. 1 receptors. J Pharmacol Exp Ther 303:356-363
137. 1 receptors. J Neurosci 18:1987-1995
138. Zhang JM, Wang HK, Ye CQ, Ge W, Chen Y, Jiang ZL, Wu CP, Poo MM, Duan S (2003) ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40:971-982
139. Krügel U, Schraft T, Regenthal R, Illes P, Kittner H (2004) Purinergic modulation of extracellular glutamate levels in the nucleus accumbens in vivo. Int J Dev Neurosci 22:565-570
140. Krügel U, Spiess O, Regenthal R, Illes P, Kittner H (2004) P2 receptors are involved in the mediation of motivation-related behaviour. Purinergic Signalling 1:21-29
141. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1-105
142. Burnstock G (1996) Purinoceptors: ontogeny and phylogeny. Drug Dev Res 39:204-242
143. Abbracchio MP, Ceruti S, Langfelder R, Cattabeni F, Saffrey MJ, Burnstock G (1995) Effects of ATP analogues and basic fibroblast growth factor on astroglial cell differentiation in primary cultures of rat striatum. Int J Dev Neurosci 13:685-693
144. Lemoli RM, Ferrari D, Fogli M, Rossi L, Pizzirani C, Forchap S, Chiozzi P, Vaselli D, Bertolini F, Foutz T, Aluigi M, Baccarani M, Di Virgilio F (2004) Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. Blood 104:1662-1670
145. Lenz G, Gottfried C, Luo Z, Avruch J, Rodnight R, Nie WJ, Kang Y, Neary JT (2000) P2Y purinoceptor subtypes recruit different mek activators in astrocytes. Br J Pharmacol 129:927-936
146. 2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc Natl Acad Sci USA 102:19138-19143
147. Hogg RC, Chipperfield H, Whyte KA, Stafford MR, Hansen MA, Cool SM, Nurcombe V, Adams DJ (2004) Functional maturation of isolated neural progenitor cells from the adult rat hippocampus. Eur J Neurosci 19:2410-2420
148. Agresti C, Meomartini ME, Amadio S, Ambrosini E, Serafini B, Franchini L, Volonte C, Aloisi F, Visentin S (2005) Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development. Glia 50:132-144
149. Agresti C, Meomartini ME, Amadio S, Ambrosini E, Volonte C, Aloisi F, Visentin S (2005) ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors. Brain Res Brain Res Rev 48:157-165
150. Lutz PL, Kabler S (1997) Release of adenosine and ATP in the brain of the freshwater turtle (Trachemys scripta) during long-term anoxia. Brain Res 769:281-286
151. Petruzzi E, Orlando C, Pinzani P, Sestini R, Del Rosso A, Dini G, Tanganelli E, Buggiani A, Pazzagli M (1994) Adenosine triphosphate release by osmotic shock and hemoglobin A1C in diabetic subjects' erythrocytes. Metabolism 43:435-440
152. Cavaliere F, D'Ambrosi N, Ciotti MT, Mancino G, Sancesario G, Bernardi G, Volonte C (2001) Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists. Neurochem Int 38:189-197
153. Cavaliere F, D'Ambrosi N, Sancesario G, Bernardi G, Volonte C (2001) Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue. Neurochem Int 38:199-207
154. Chow SC, Kass GEN, Orrenius S (1997) Purines and their roles in apoptosis. Neuropharmacology 36:1149-1156
155. Abbracchio MP, Burnstock G (1998) Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 78:113-145
156. Burnstock G (1999) Current status of purinergic signalling in the nervous system. Prog Brain Res 120:3-10
157. Ryu JK, Kim J, Choi SH, Oh YJ, Lee YB, Kim SU, Jin BK (2002) ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport 13:1611-1615
158. Choi D (1998) Antagonizing excitotoxicity: a therapeutic strategy for stroke? Mt Sinai J Med 65:133-138
159. Watkins JC, Collingridge GL (1989) The NMDA receptor. Oxford University Press, London, UK
160. Norenberg MD (1994) Astrocyte responses to CNS injury. J Neuropathol Exp Neurol 53:213-220
161. Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: GFAP - thirty-one years (1969-2000). Neurochem Res 25:1439-1451
162. McGraw J, Hiebert GW, Steeves JD (2001) Modulating astrogliosis after neurotrauma. J Neurosci Res 63:109-115
163. Peković S, Filipovic R, Subasic S, Lavrnja I, Stojkov D, Nedeljkovic N, Rakic L, Stojiljkovic M (2005) Downregulation of glial scarring after brain injury: the effect of purine nucleoside analogue ribavirin. Ann N Y Acad Sci 1048:296-310
164. Frederickson RC (1992) Astroglia in Alzheimer's disease. Neurobiol Aging 13:239-253
165. Franke H (1995) Influence of chronic alcohol treatment on the GFAP-immunoreactivity in astrocytes of the hippocampus in rats. Acta Histochem 97:263-271
166. D'Amelio FE, Smith ME, Eng LF (1990) Sequence of tissue responses in the early stages of experimental allergic encephalomyelitis (EAE): immunohistochemical, light microscopic, and ultrastructural observations in the spinal cord. Glia 3:229-240
167. Koizumi S, Fujishita K, Inoue K (2005) Regulation of cell-to-cell communication mediated by astrocytic ATP in the CNS. Purinergic Signalling 1:211-217
168. Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 19:13-18
169. Ciccarelli R, Ballerini P, Sabatino G, Rathbone MP, D'Onofrio M, Caciagli F, Di Iorio P (2001) Involvement of astrocytes in purine-mediated reparative processes in the brain. Int J Dev Neurosci 19:395-414
170. Brambilla R, Burnstock G, Bonazzi A, Ceruti S, Cattabeni F, Abbracchio MP (1999) Cyclooxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br J Pharmacol 126:563-567
171. Brambilla R, Neary JT, Cattabeni F, Cottini L, D'Ippolito G, Schiller PC, Abbracchio MP (2002) Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. J Neurochem 83:1285-1296
172. 2+ signaling involves extracellular kinase activation in cerebellar astrocytes. J Neurosci Res 81:789-796
173. Planas AM, Justicia C, Soriano MA, Ferrer I (1998) Epidermal growth factor receptor in proliferating reactive glia following transient focal ischemia in the rat brain. Glia 23:120-129
174. Fumagalli M, Brambilla R, D'Ambrosi N, Volonte C, Matteoli M, Verderio C, Abbracchio MP (2003) Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors. Glia 43:203-218
175. 7 receptors stimulate AKT phosphorylation in astrocytes. Br J Pharmacol 141:1106-1117
176. Koizumi S, Inoue K (2004) Regulation by astrocytic ATP of synaptic transmission. Nippon Yakurigaku Zasshi 123:389-396
177. 1 receptors. Glia 49:288-300
178. 7 nucleotide receptors that mediate neuroinflammatory responses in astrocytes and microglial cells. Biomed Res 14:47-61
179. 2 receptors. Glia 22:360-370
180. 4 nucleotide receptors. Biochem Pharmacol 65:923-931
181. 7 receptor expression and function in human astrocytes. Glia 49:245-258
182. 7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes. Int J Immunopathol Pharmacol 18:417-430
183. Neary JT, Kang Y, Willoughby KA, Ellis EF (2003) Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J Neurosci 23:2348-2356
184. Neary JT, Kang Y, Tran M, Feld J (2005) Traumatic injury activates protein kinase B/Akt in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors. J Neurotrauma 22:491-500
185. 2 receptor agonist. J Neurosci Res 38:399-406
186. Franke H, Krügel U, Illes P (1999) P2 receptor-mediated proliferative effects on astrocytes in vivo. Glia 28:190-200
187. Franke H, Krügel U, Schmidt R, Grosche J, Reichenbach A, Illes P (2001) P2 receptor-types involved in astrogliosis in vivo. Br J Pharmacol 134:1180-1189
188. Franke H, Krügel U, Grosche J, Heine C, Härtig W, Allgaier C, Illes P (2004) P2Y receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 127:431-441
189. 1 receptor expression in the brain after sensitisation with d-amphetamine. Psychopharmacology (Berl) 167:187-194
190. i/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Brain Res Mol Brain Res 118:10-23
191. Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44:5-21
192. Bear MF, Malenka RC (1994) Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol 4:389-399
193. Otani S, Blond O, Desce JM, Crepel F (1998) Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex. Neuroscience 85:669-676
194. Nieus T, Sola E, Mapelli J, Saftenku E, Rossi P, D'Angelo E (2006) LTP regulates burst initiation and frequency at mossy fiber-granule cell synapses of rat cerebellum: experimental observations and theoretical predictions. J Neurophysiol 95:686-699
195. Picconi B, Pisani A, Barone I, Bonsi P, Centonze D, Bernardi G, Calabresi P (2005) Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. Neurotoxicology 26:779-783
196. Dityatev AE, Bolshakov VY (2005) Amygdala, long-term potentiation, and fear conditioning. Neuroscientist 11:75-88
197. Herrero JF, Laird JM, Lopez-Garcia JA (2000) Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol 61:169-203
198. Wieraszko A, Ehrlich YH (1994) On the role of extracellular ATP in the induction of long-term potentiation in the hippocampus. J Neurochem 63:1731-1738
199. Chen W, Wieraszko A, Hogan MV, Yang HA, Kornecki E, Ehrlich YH (1996) Surface protein phosphorylation by ecto-protein kinase is required for the maintenance of hippocampal long-term potentiation. Proc Natl Acad Sci USA 93:8688-8693
200. Fujii S, Kato H, Furuse H, Ito K, Osada H, Hamaguchi T, Kuroda Y (1995) The mechanism of ATP-induced long-term potentiation involves extracellular phosphorylation of membrane proteins in guinea-pig hippocampal CA1 neurons. Neurosci Lett 187:130-132
201. Fujii S, Kuroda Y, Ito K, Kato H (2000) Long-term potentiation induction - a synaptic catch mechanism released by extracellular phosphorylation. Neuroscience 96:259-266
202. 3 receptors by ecto-protein kinase C. J Neurosci 25:7734-7742
203. 3 receptors after substitution by Asp of Ser/Thr residues in protein kinase C phosphorylation sites of their ecto-domains. Neurosci Lett 393:78-83
204. Wang Y, Haughey NJ, Mattson MP, Furukawa K (2004) Dual effects of ATP on rat hippocampal synaptic plasticity. Neuroreport 15:633-636
205. da Silva BM, de Mendonca A, Ribeiro JA (2005) Long-term depression is not modulated by ATP receptors in the rat CA1 hippocampal region. Neurosci Lett 383:345-349
206. Wirkner K, Köles L, Thümmler S, Luthardt J, Poelchen W, Franke H, Fürst S, Illes P (2002) Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex. Neuropharmacology 42:476-488
207. 1 receptors inhibit both strength and plasticity of glutamatergic synaptic neurotransmission in the rat prefrontal cortex. Synapse 57:235-238
208. Hasko G, Pacher P, Vizi ES, Illes P (2005) Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 26:511-516
209. 2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices. Neuroscience 122:111-121
210. Calabresi P, Saulle E, Centonze D, Pisani A, Marfia GA, Bernardi G (2002) Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability. Brain 125:844-860
211. Zhang Y, Deng P, Li Y, Xu ZC (2005) Enhancement of excitatory synaptic transmission in spiny neurons after transient forebrain ischemia. J Neurophysiol 95:1537-1544
212. Gysbers JW, Rathbone MP (1992) Guanosine enhances NGF-stimulated neurite outgrowth in PC12 cells. Neuroreport 3:997-1000
213. Heilbronn A, Maienschein V, Carstensen K, Gann W, Zimmermann H (1995) Crucial role of ecto-5′-nucleotidase in differentiation and survival of developing neural cells. Neuroreport 7:257-261
214. Gysbers JW, Rathbone MP (1996) GTP and guanosine synergistically enhance NGF-induced neurite outgrowth from PC12 cells. Int J Dev Neurosci 14:19-34
215. Höpker VH, Saffrey MJ, Burnstock G (1996) Neurite outgrowth of striatal neurons in vitro: involvement of purines in the growth-promoting effect of myenteric plexus explants. Int J Dev Neurosci 14:439-451
216. Benowitz LI, Jing Y, Tabibiazar R, Jo SA, Petrausch B, Stuermer CA, Rosenberg PA, Irwin N (1998) Axon outgrowth is regulated by an intracellular purine-sensitive mechanism in retinal ganglion cells. J Biol Chem 273:29626-29634
217. 2+ level and modulation of nerve growth factor action on pheochromocytoma PC12h cells by extracellular ATP. Meikai Daigaku Shigaku Zasshi 19:221-229
218. i rise and dopamine secretion in PC12 cells. J Neurochem 66:124-130
219. Gysbers JW, Guarnieri S, Mariggio MA, Pietrangelo T, Fano G, Rathbone MP (2000) Extracellular guanosine 5′ triphosphate enhances nerve growth factor-induced neurite outgrowth via increases in intracellular calcium. Neuroscience 96:817-824
220. Pooler AM, Guez DH, Benedictus R, Wurtman RJ (2005) Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12. Neuroscience 134:207-214
221. Chorna NE, Santiago-Perez LI, Erb L, Seye CI, Neary JT, Sun GY, Weisman GA, Gonzalez FA (2004) P2Y receptors activate neuroprotective mechanisms in astrocytic cells. J Neurochem 91:119-132
222. Heine C, Heimrich B, Vogt J, Wegner A, Illes P, Franke H (2006) P2 receptor-stimulation influences axonal outgrowth in the developing hippocampus in vitro. Neuroscience 138:303-311
223. Abbracchio MP, Ceruti S, Bolego C, Puglisi L, Burnstock G, Cattabeni F (1996) Trophic roles of P2 purinoceptors in central nervous system astroglial cells. Ciba Found Symp 198:142-147
224. Di Virgilio F, Chiozzi P, Falzoni S, Ferrari D, Sanz JM, Venketaraman V, Baricordi OR (1998) Cytolytic P2X purinoceptors. Cell Death Differ 5:191-199
225. Neary JT (1996) Trophic actions of extracellular ATP on astrocytes, synergistic interactions with fibroblast growth factors and underlying signal transduction mechanisms. Ciba Found Symp 198:130-139
226. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio F (1997) Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159:1451-1458
227. Ferrari D, Los M, Bauer MK, Vandenabeele P, Wesselborg S, Schulze-Osthoff K (1999) P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett 447:71-75
228. Inoue K (2002) Microglial activation by purines and pyrimidines. Glia 40:156-163
229. Di Virgilio F (2005) Purinergic mechanisms in the immune system: a signal of danger for dendritic cells. Purinergic Signalling 1:205-209
230. Buday PV, Carr CJ, Myga TS (1961) A pharmacologic study of some nucleosides and nucleotides. J Pharm Pharmacol 13:290-299
231. Knutsen LJ, Murray TF (1997) Adenosine and ATP in epilepsy. In: Jacobson KA, Jarvis MF (eds) Purinergic approaches in experimental therapeutics. Wiley-Liss, pp 423-447
232. A receptor-mediated mechanism in the gerbil hippocampus. Brain Res Mol Brain Res 116:168-175
233. 7 receptor expression in the gerbil hippocampus. Brain Res Mol Brain Res 121:12-18
234. Vianna EP, Ferreira AT, Naffah-Mazzacoratti MG, Sanabria ER, Funke M, Cavalheiro EA, Fernandes MJ (2002) Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: fluorimetric, immunohistochemical, and Western blot studies. Epilepsia 43(Suppl 5):227-229
235. 2 subunit of purinergic receptors, PSA-NCAM, and GAP-43 immunoreactivities: light and electron microscopic study. J Comp Neurol 457:159-174
236. Haughey NJ, Mattson MP (2003) Alzheimer's amyloid beta-peptide enhances ATP/gap junction-mediated calcium-wave propagation in astrocytes. Neuromolecular Med 3:173-180
237. 7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278:13309-13317
238. Bringmann A, Pannicke T, Uhlmann S, Kohen L, Wiedemann P, Reichenbach A (2002) Membrane conductance of Müller glial cells in proliferative diabetic retinopathy. Can J Ophthalmol 37:221-227
239. 1 purinergic receptor in the human brain: striking neuronal localisation. J Comp Neurol 421:374-384
240. 1 purinergic receptor in Alzheimer's disease. Neuroreport 11:3799-3803
241. Krügel U, Kittner H, Franke H, Illes P (2001) Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo. Neuropharmacology 40:1084-1093
242. Kittner H, Krügel U, Illes P (2001) The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2′4′-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats. Neuroscience 102:241-243
243. Gerevich Z, Illes P (2004) P2Y receptors and pain transmission. Purinergic Signalling 1:3-10
244. Gerevich Z, Borvendeg SJ, Schröder W, Franke H, Wirkner K, Nörenberg W, Fürst S, Gillen C, Illes P (2004) Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia. J Neurosci 24:797-807
245. Li C, Aguayo L, Peoples RW, Weight FF (1993) Ethanol inhibits a neuronal ATP-gated ion channel. Mol Pharmacol 44:871-875
246. Weight FF, Li C, Peoples RW (1999) Alcohol action on membrane ion channels gated by extracellular ATP (P2X receptors). Neurochem Int 35:143-152
247. Li C, Xiong K, Weight FF (2000) Ethanol inhibition of adenosine 5′-triphosphate-activated current in freshly isolated adult rat hippocampal CA1 neurons. Neurosci Lett 295:77-80
248. 4 receptors expressed in Xenopus oocytes. Br J Pharmacol 130:1394-1398
249. 4 receptor subtypes expressed in Xenopus oocytes. Neuropharmacology 49:243-253
250. Davies DL, Machu TK, Guo Y, Alkana RL (2002) Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent. Alcohol Clin Exp Res 26:773-778
251. Phillis JW, O'Regan MH, Perkins LM (1993) Adenosine 5′-triphosphate release from the normoxic and hypoxic in vivo rat cerebral cortex. Neurosci Lett 151:94-96
252. 3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res 823:183-190
253. 7 receptor. Neuropharmacology 36:1277-1283
254. 4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 120:85-98
255. 7 and oxygen/glucose deprivation in organotypic hippocampal cultures. J Cereb Blood Flow Metab 24:392-398
256. 7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol 63:686-699
257. 7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab (in press)
258. Cavaliere F, Sancesario G, Bernardi G, Volonte C (2002) Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: role of P2 and NGFRp75 receptors. J Neurochem 83:1129-1138
259. Wirkner K, Kofalvi A, Fischer W, Günther A, Franke H, Gröger-Arndt H, Nörenberg W, Madarasz E, Vizi ES, Schneider D, Sperlagh B, Illes P (2005) Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. J Neurochem 95:1421-1437
260. 7). Science 272:735-738
261. 7 receptor of microglial cells: a novel immunomodulatory receptor. Prog Brain Res 120:355-368
262. Virginio C, MacKenzie A, Rassendren FA, North RA, Surprenant A (1999) Pore dilation of neuronal P2X receptor channels. Nat Neurosci 2:315-321
263. 7 receptors. Am J Physiol Cell Physiol 279:C1189-C1197
264. Pubill D, Dayanithi G, Siatka C, Andres M, Dufour MN, Guillon G, Mendre C (2001) ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2X receptors. Cell Calcium 29:299-309
265. 7 receptor signalling complex. EMBO J 20:6347-6358
266. 7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase. J Neurosci 22:5938-5945
267. Atkinson L, Milligan CJ, Buckley NJ, Deuchars J (2002) An ATP-gated ion channel at the cell nucleus. Nature 420:42
268. 7 receptor subtypes. Br J Pharmacol 135:1616-1626
269. 7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J Neurochem 81:1196-1211
270. 7 purinergic receptors in the monkey retina. J Comp Neurol 459:267-277
271. 7 receptors in rat thoracolumbar sympathetic neurones. J Neurochem 90:359-367
272. 7 receptor expression in rodent brain. J Neurosci 24:6307-6314
273. -/- mice. Neuroreport 15:2387-2391
274. 7 ATP channel. Biochem Biophys Res Commun 332:17-27
275. 7 receptors in rat brain: presence in synaptic terminals and granule cells. Neurochem Res 28:1597-1605
276. Hervas C, Perez-Sen R, Miras-Portugal MT (2005) Presence of diverse functional P2X receptors in rat cerebellar synaptic terminals. Biochem Pharmacol 70:770-785
277. Sanz JM, Di Virgilio F (2000) Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells. J Immunol 164:4893-4898
278. 7 receptors in ischemic and excitotoxic brain injury in vivo. J Cereb Blood Flow Metab 23:381-384
279. 1 purinergic receptor in neurons and glial cells of the central nervous system. Brain Res Mol Brain Res 78:50-58
280. Lämmer A, Günther A, Kittner H, Franke H, Krügel U, Schneider D, Illes P (2004) In vivo effects of inhibition of P2 receptors after focal cerebral ischemia in the rat. Int J Dev Neurosci 22:587
281. 2 purinergic receptors in precerebellar nuclei. Neuroscience 115:425-434
282. Viscomi MT, Florenzano F, Amadio S, Bernardi G, Molinari M (2005) Partial resistance of ataxin-2-containing olivary and pontine neurons to axotomy-induced degeneration. Brain Res Bull 66:212-221
283. 3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain 80:273-282
284. 3 mRNA expression by peripheral nerve injury in intact and injured neurons in the rat sensory ganglia. Pain 91:351-360
285. 3 receptor-dependent sensory functions in A/J inbred mouse strain. Eur J Neurosci 15:1444-1450
286. Franke H, Grosche J, Schädlich H, Krügel U, Allgaier C, Illes P (2001) P2X receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 108:421-429
287. Franke H, Krügel U, Grosche J, Illes P (2003) Immunoreactivity for glial fibrillary acidic protein and P2 receptor expression on astrocytes in vivo. Drug Dev Res 59:175-189
288. 7 ATP receptor-mediated modulation of astrocyte proliferation and coupling. Drug Dev Res 50:108
289. 7 receptors. J Neurochem 73:334-343
290. 7 receptor-mediated phospholipase D activation is regulated by both PKC-dependent and PKC-independent pathways in a rat brain-derived Type-2 astrocyte cell line, RBA-2. Cell Signal 14:83-92
291. 7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci 21:7135-7142
292. 7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am J Physiol Cell Physiol 284:C571-C581
293. Erlinge D, You J, Wahlestedt C, Edvinsson L (1995) Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur J Pharmacol 289:135-149
294. Araque A, Parpura V, Sanzgiri RP, Haydon PG (1999) Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22:208-215
295. 7 like channels in cultured mouse astrocytes. Drug Dev Res 50:92
296. 7) receptors regulate intracellular calcium and purine release. Neuroreport 7:2533-2537
297. 3-dependent mechanism. Glia 37:8-18
298. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R (2003) Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 183:25-33
299. Günther A, Küppers-Tiedt L, Schneider PM, Kunert I, Berrouschot J, Schneider D, Rossner S (2005) Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci 21:3189-3194
300. Giulian D (1993) Reactive glia as rivals in regulating neuronal survival. Glia 7:102-110
301. Stoll G, Jander S, Schroeter M (2000) Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J Neural Transm Suppl 59:81-89
302. Cavaliere F, Dinkel K, Reymann K (2005) Microglia response and P2 receptor participation in oxygen/glucose deprivation-induced cortical damage. Neuroscience 136:615-623
303. Ferrari D, Villalba M, Chiozzi P, Falzoni S, Ricciardi-Castagnoli P, Di Virgilio F (1996) Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol 156:1531-1539
304. Ferrari D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F (1997) Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J Exp Med 185:579-582
305. Hide I, Tanaka M, Inoue A, Nakajima K, Kohsaka S, Inoue K, Nakata Y (2000) Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J Neurochem 75:965-972
306. Nedergaard M, Ransom B, Goldman SA (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26:523-530
307. Streit WJ, Conde JR, Fendrick SE, Flanary BE, Mariani CL (2005) Role of microglia in the central nervous system's immune response. Neurol Res 27:685-691
308. Streit WJ, Mrak RE, Griffin WS (2004) Microglia and neuroinflammation: a pathological perspective. J Neuroinflamm 1:14-18
309. Vilhardt F (2005) Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 37:17-21
310. Xiang Z, Chen M, Ping J, Dunn P, Lv J, Jiao B, Burnstock G (2006) Microglial morphology and its transformation after challenge by extracellular ATP in vitro. J Neurosci Res 83:91-101
311. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752-758
312. Xiang Z, Burnstock G (2005) Expression of P2X receptors on rat microglial cells during early development. Glia 52:119-126
313. Boucsein C, Zacharias R, Farber K, Pavlovic S, Hanisch UK, Kettenmann H (2003) Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur J Neurosci 17:2267-2276
314. 12 in microglia in rat brain. Glia 44:242-250
315. Bianco F, Fumagalli M, Pravettoni E, D'Ambrosi N, Volonte C, Matteoli M, Abbracchio MP, Verderio C (2005) Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res Brain Res Rev 48:144-156
316. Ferrari D, Wesselborg S, Bauer MK, Schulze-Osthoff K (1997) Extracellular ATP activates transcription factor NF-kappa B through the P2Z purinoreceptor by selectively targeting NF-kappa B p65. J Cell Biol 139:1635-1643
317. Dhawan P, Richmond A (2002) A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. J Biol Chem 277:7920-7928
318. 7 nucleotide receptor. J Biol Chem 275:26792-26798
319. Shigemoto-Mogami Y, Koizumi S, Tsuda M, Ohsawa K, Kohsaka S, Inoue K (2001) Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J Neurochem 78:1339-1349
320. 2+-dependent plasminogen release from cultured microglia. Br J Pharmacol 123:1304-1310
321. Ohtani Y, Minami M, Satoh M (2000) Expression of inducible nitric oxide synthase mRNA and production of nitric oxide are induced by adenosine triphosphate in cultured rat microglia. Neurosci Lett 293:72-74
322. 7 receptor: death or life? Purinergic Signalling 1:219-227
323. 2 receptors in differentiated rat pheochromocytoma PC12 cells. Life Sci 66:1849-1859
324. 7-transfected HEK293 cells. Mol Biol Cell 14:2655-2664
325. 7 receptors. Am J Physiol 275:F962-F971
326. 7 purinoceptor-stimulated TGF-beta 1 mRNA expression involves PKC/MAPK signalling pathway in a rat brain-derived type-2 astrocyte cell line, RBA-2. Cell Signal 15:1129-1137
327. 7 receptor-mediated calcium signalling of cultured type-2 astrocyte cell line, RBA-2. Cell Signal 17:1384-1396
328. 1 receptor stimulate mitogen-activated protein kinases and induce apoptosis. J Biol Chem 276:16379-16390
329. Wang Y, Chang CF, Morales M, Chiang YH, Harvey BK, Su TP, Tsao LI, Chen S, Thiemermann C (2003) Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain. J Neurosci 23:7958-7965
330. Volonte C, Merlo D (1996) Selected P2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons. J Neurosci Res 45:183-193
331. Volonte C, Ciotti MT, D'Ambrosi N, Lockhart B, Spedding M (1999) Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. Neuropharmacology 38:1335-1342
332. Yamakuni H, Kawaguchi N, Ohtani Y, Nakamura J, Katayama T, Nakagawa T, Minami M, Satoh M (2002) ATP induces leukemia inhibitory factor mRNA in cultured rat astrocytes. J Neuroimmunol 129:43-50
333. Amadio S, D'Ambrosi N, Trincavelli ML, Tuscano D, Sancesario G, Bernadi G, Martini C, Volonte C (2005) Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons. Neurochem Int 47:334-342
334. 7 receptor function with a monoclonal antibody. Blood 92:3521-3528
335. 7 receptor pore dilation: pharmacological and functional consequences. Drug Dev Res 53:60-65
336. Kharlamov A, Jones SC, Kim DK (2002) Suramin reduces infarct volume in a model of focal brain ischemia in rats. Exp Brain Res 147:353-359
337. Krügel U, Kittner H, Franke H, Illes P (2001) Accelerated functional recovery after neuronal injury by P2 receptor blockade. Eur J Pharmacol 420:R3-R4
338. Weissman TA, Riquelme PA, Ivic L, Flint AC, Kriegstein AR (2004) Calcium waves propagate through radial glial cells and modulate proliferation in the developing neocortex. Neuron 43:647-661
339. Kunapuli SP, Dorsam RT, Kim S, Quinton TM (2003) Platelet purinergic receptors. Curr Opin Pharmacol 3:175-180
340. 12 receptor in platelet activation. J Clin Invest 113:340-345
341. 1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2. Proc Natl Acad Sci USA 102:8042-8047
342. Chattaraj SC (2001) Cangrelor AstraZeneca. Curr Opin Investig Drugs 2:250-255
343. Burnstock G (2002) Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med 2:45-53
344. Mamedova L, Capra V, Accomazzo MR, Gao ZG, Ferrario S, Fumagalli M, Abbracchio MP, Rovati GE, Jacobson KA (2005) CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochem Pharmacol 71:115-125
345. 1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia. Int J Immunopathol Pharmacol 18:255-268
346. Kennedy C, Assis TS, Currie AJ, Rowan EG (2003) Crossing the pain barrier: P2 receptors as targets for novel analgesics. J Physiol 553:683-694
347. Günther A, Manaenko A, Franke H, Wagner A, Schneider D, Berrouschot J, Reinhardt R (2004) Hyperbaric and normobaric reoxygenation of hypoxic rat brain slices-impact on purine nucleotides and cell viability. Neurochem Int 45:1125-1132
348. 2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA 99:17179-17184
349. Lämmer A, Günther A, Beck A, Krügel U, Kittner H, Schneider D, Illes P, Franke H (2006) Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischemia induced injury in rats. Eur J Neurosci (in press)